Filter
400
Text search:
HIV
coinfection
Featured
50
106
Language
Document type
247
56
52
10
9
8
7
6
2
1
1
Countries / Regions
18
17
16
15
13
10
8
7
7
6
6
6
6
6
6
6
6
5
5
4
4
4
4
4
4
3
3
3
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
147
53
7
6
6
5
4
Toolboxes
128
94
28
8
7
6
3
3
2
2
2
2
1
1
1
1
1
1
Buruli ulcer (BU) is a skin-related neglected tropical disease (skin NTD) caused by infection with
Mycobacterium ulcerans. BU is the third most common mycobacterial disease after tuberculosis and leprosy
in people who are not immunocompromised. The infection manifests in non-ulcerative forms as no
...
Exciting new treatment approaches make the management of hepatitic C one of the most rapidly developing areas of medicine. The Flying Publisher short Guide to Hepatitis C is an up-to-date source of information for physicians, residents and advanced medical students.
Clinical Infectious Diseases 2010; 50:291–322
Policy statement.
Federal Bureau of Prisons
Clinical Practice Guidelines
January 1010
Surveillance Report
Towards a world free of tuberculosis
10–21 March 2014
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
The main objective of these guidelines is to provide guidance on up-to-date, uniform, evidence-informed practices for suspecting, diagnosing and managing various forms of extra-pulmonary tuberculosis (EPTB) at all levels of healthcare delivery. They can then contribute to the National Programme to i
...
Addressing comorbidities and risk factors for TB is a crucial component of Pillar one of the End TB Strategy, which focuses on integrated patient-centred care and prevention, including action on TB and comorbidities. The Framework for collaborative action on TB and comorbidities aims to support coun
...
The Lancet Regional Health - Americas 2024;36: 100821 https://doi.org/10.1016/j.lana.2024.100821
Technical Brief
Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection
